{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T00:07:14Z","timestamp":1758758834164,"version":"3.44.0"},"reference-count":45,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T00:00:00Z","timestamp":1758672000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:sec><jats:title>Objective<\/jats:title><jats:p>As an old drug with a new application in rare diseases with epileptic symptoms, fenfluramine may have potential unrecognized adverse events. Because limited real-world data exist on Lennox-Gastaut syndrome (LGS) and Dravet syndrome (DS) populations, some rare adverse events (AEs) are easily overlooked. The purpose of this study was to comprehensively evaluate the characteristics of adverse events of fenfluramine.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>The data were extracted from the Food and Drug Administration (FDA) Adverse Event Reporting System (FAERS) database from the third quarter of 2020 to the fourth quarter of 2024 for data cleaning and analysis. To ensure the accuracy and reliability of the study, adverse events of fenfluramine were analyzed using the Reporting Odds Ratio (ROR), Bayesian Confidence Propagation Neural Network (BCPNN), Proportional Reporting Ratio (PRR), and Multi-Item Gamma Poisson Shrinker (MGPS) methods.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Following data deduplication and screening, a total of 9,868 fenfluramine-related adverse event reports were included in this study. The analysis showed that fenfluramine-induced AEs occurred across 24 system organ classes (SOCs). In addition to the typical side effects such as seizure, somnolence, lethargy, status epilepticus, balance disorder and sedation, it is important to pay attention to emerging risks such as pericardial effusion, crying, pneumonia, oxygen saturation decreased, muscle twitching, insomnia, aggression, agitation, mood swings, urinary retention and aortic dilatation. It is notable that aortic valve incompetence and epilepsy are more likely to occur in males and females are more prone to encountering nervous system adverse reactions after fenfluramine treatment. LGS had higher risk after fenfluramine treatment in mitral valve incompetence, constipation, urinary tract infection, fall, lethargy and atonic seizures, while DS had higher risk in pyrexia, illness, nasopharyngitis, influenza, decreased appetite, seizure, generalized tonic-clonic seizure, status epilepticus, myoclonic epilepsy, aggression.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>This study provided valuable evidence on the real-world safety of fenfluramine, suggesting that clinicians should place greater emphasis on monitoring its adverse effects during use. Medical staff should pay more attention to cardiac AEs on LGS patients and nervous system AEs on DS patients throughout the entire duration of fenfluramine treatment.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fphar.2025.1682788","type":"journal-article","created":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T05:42:32Z","timestamp":1758692552000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Pharmacovigilance study on old drugs repurposed for rare diseases across different indications: the case of fenfluramine"],"prefix":"10.3389","volume":"16","author":[{"given":"Jiahong","family":"Zhong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhuomiao","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junling","family":"Xue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xihui","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,9,24]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1007\/978-3-642-38664-0_15","article-title":"Serotonin transporter and serotonin receptors","volume":"218","author":"Adnot","year":"2013","journal-title":"Handb. Exp. Pharmacol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.acvd.2013.02.003","article-title":"Drug-induced valvular heart disease: an update","volume":"106","author":"Andrejak","year":"2013","journal-title":"Archives Cardiovasc. Dis."},{"key":"B3","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1007\/s10072-017-3188-y","article-title":"Lennox-Gastaut syndrome: a comprehensive review","volume":"39","author":"Asadi-Pooya","year":"2018","journal-title":"Neurol. Sci."},{"key":"B4","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1002\/epi4.13075","article-title":"Refining management strategies for Lennox-Gastaut syndrome: updated algorithms and practical approaches","volume":"10","author":"Auvin","year":"2025","journal-title":"Epilepsia open"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1111\/epi.18241","article-title":"Fenfluramine treatment for Dravet syndrome: long term real-world analysis demonstrates safety and reduced health care burden","volume":"66","author":"Boncristiano","year":"2025","journal-title":"Epilepsia"},{"key":"B6","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1111\/epi.12567","article-title":"Lennox-Gastaut syndrome: a consensus approach to differential diagnosis","volume":"55","author":"Bourgeois","year":"2014","journal-title":"Epilepsia"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1016\/j.euf.2021.07.001","article-title":"Drug-induced urinary retention: an analysis of a national spontaneous adverse drug reaction reporting database","volume":"8","author":"Crisafulli","year":"2022","journal-title":"Eur. Urol. Focus"},{"key":"B8","doi-asserted-by":"publisher","first-page":"832929","DOI":"10.3389\/fphar.2022.832929","article-title":"Improving therapy of pharmacoresistant epilepsies: the role of fenfluramine","volume":"13","author":"Dini","year":"2022","journal-title":"Front. Pharmacol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"2013","DOI":"10.2147\/ndt.S417676","article-title":"Reintroducing fenfluramine as a treatment for seizures: current knowledge, recommendations and gaps in understanding","volume":"19","author":"Dini","year":"2023","journal-title":"Neuropsychiatric Dis. Treat."},{"key":"B10","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1186\/s13019-025-03370-5","article-title":"Incidence of secondary pericardial effusions associated with different etiologies: a comprehensive review of literature","volume":"20","author":"Ebrahimi","year":"2025","journal-title":"J. Cardiothorac. Surg."},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.3390\/children9081159","article-title":"A review of pharmacology, clinical efficacy, and safety in epilepsy","volume":"9","author":"Fenfluramine","year":"2022","journal-title":"Child. Basel, Switz."},{"key":"B12","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1007\/s40265-023-01881-w","article-title":"Fenfluramine: a review in Dravet and lennox-gastaut syndromes","volume":"83","author":"Frampton","year":"2023","journal-title":"Drugs"},{"key":"B13","doi-asserted-by":"publisher","first-page":"46","DOI":"10.3389\/fphar.2015.00046","article-title":"Central serotonin-2A (5-HT2A) receptor dysfunction in depression and epilepsy: the missing link?","volume":"6","author":"Guiard","year":"2015","journal-title":"Front. Pharmacol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"2247","DOI":"10.2165\/11596680-000000000-00000","article-title":"Serotonergic anti-obesity agents: past experience and future prospects","volume":"71","author":"Halford","year":"2011","journal-title":"Drugs"},{"key":"B15","doi-asserted-by":"publisher","first-page":"7211","DOI":"10.1038\/s41380-021-01220-z","article-title":"5-HT recruits distinct neurocircuits to inhibit hunger-driven and non-hunger-driven feeding","volume":"26","author":"He","year":"2021","journal-title":"Mol. psychiatry"},{"key":"B16","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1016\/j.yfrne.2009.05.005","article-title":"Oxytocin, vasopressin, and human social behavior","volume":"30","author":"Heinrichs","year":"2009","journal-title":"Front. Neuroendocrinol."},{"key":"B17","first-page":"235","article-title":"Sex and gender differences in epilepsy","volume-title":"Int. Rev. Neurobiol.","author":"Hophing","year":"2022"},{"key":"B18","doi-asserted-by":"publisher","first-page":"e5768","DOI":"10.1002\/pds.5768","article-title":"Adverse drug reaction signal detection methods in spontaneous reporting system: a systematic review","volume":"33","author":"Jiao","year":"2024","journal-title":"Pharmacoepidemiol. drug Saf."},{"key":"B19","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1111\/jcpt.13024","article-title":"Time-to-onset analysis of amiodarone-associated thyroid dysfunction","volume":"45","author":"Kinoshita","year":"2020","journal-title":"J. Clin. Pharm. Ther."},{"key":"B20","doi-asserted-by":"publisher","first-page":"2818","DOI":"10.1002\/acn3.52211","article-title":"Clinical trials for Lennox-Gastaut syndrome: challenges and priorities","volume":"11","author":"Knowles","year":"2024","journal-title":"Ann. Clin. Transl. neurology"},{"key":"B21","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1001\/jamaneurol.2022.0829","article-title":"Efficacy and safety of fenfluramine for the treatment of seizures associated with lennox-gastaut syndrome: a randomized clinical trial","volume":"79","author":"Knupp","year":"2022","journal-title":"JAMA neurol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1111\/epi.17431","article-title":"Fenfluramine provides clinically meaningful reduction in frequency of drop seizures in patients with Lennox-Gastaut syndrome: interim analysis of an open-label extension study","volume":"64","author":"Knupp","year":"2023","journal-title":"Epilepsia"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1038\/nm764","article-title":"Function of the serotonin 5-hydroxytryptamine 2B receptor in pulmonary hypertension","volume":"8","author":"Launay","year":"2002","journal-title":"Nat. Med."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1485190","DOI":"10.3389\/fphar.2024.1485190","article-title":"A real-world pharmacovigilance analysis of adverse events associated with irbesartan using the FAERS and JADER databases","volume":"15","author":"Liu","year":"2024","journal-title":"Front. Pharmacol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"8416","DOI":"10.3390\/ijms22168416","article-title":"An emerging role for sigma-1 receptors in the treatment of developmental and epileptic encephalopathies","volume":"22","author":"Martin","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1080\/14712598.2021.1948529","article-title":"The impact of anti-TNF\u03b1 agents on weight-related changes: new insights from a real-world pharmacovigilance study using the FDA adverse event reporting system (FAERS) database","volume":"21","author":"Mazhar","year":"2021","journal-title":"Expert Opin. Biol. Ther."},{"key":"B27","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/s0006-8993(99)01953-8","article-title":"D-fenfluramine activates rat oxytocinergic and vasopressinergic neurons through different mechanisms","volume":"851","author":"Mikkelsen","year":"1999","journal-title":"Brain Res."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1007\/s13311-023-01397-x","article-title":"Lennox-gastaut syndrome: current treatments, novel therapeutics, and future directions","volume":"20","author":"Nelson","year":"2023","journal-title":"Neurother. J. Am. Soc. Exp. Neurother."},{"key":"B29","doi-asserted-by":"publisher","first-page":"107866","DOI":"10.1016\/j.pharmthera.2021.107866","article-title":"Fenfluramine repurposing from weight loss to epilepsy: what we do and do not know","volume":"226","author":"Odi","year":"2021","journal-title":"Pharmacol. and Ther."},{"key":"B30","doi-asserted-by":"publisher","first-page":"116174","DOI":"10.1016\/j.jpba.2024.116174","article-title":"Innovative LC-MS\/MS method for therapeutic drug monitoring of fenfluramine and cannabidiol in the plasma of pediatric patients with epilepsy","volume":"245","author":"Pigliasco","year":"2024","journal-title":"J. Pharm. Biomed. analysis"},{"key":"B31","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.yebeh.2017.05.021","article-title":"Assessment of treatment patterns and healthcare costs associated with probable Lennox-Gastaut syndrome","volume":"73","author":"Pi\u00f1a-Garza","year":"2017","journal-title":"Epilepsy and Behav. E and B."},{"key":"B32","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/nrd.2018.168","article-title":"Drug repurposing: progress, challenges and recommendations","volume":"18","author":"Pushpakom","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"B33","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1016\/j.pain.2011.11.025","article-title":"A systematic literature review of 10 years of research on sex\/gender and experimental pain perception - part 1: are there really differences between women and men?","volume":"153","author":"Racine","year":"","journal-title":"Pain"},{"key":"B34","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/j.pain.2011.11.026","article-title":"A systematic literature review of 10 years of research on sex\/gender and pain perception - part 2: do biopsychosocial factors alter pain sensitivity differently in women and men?","volume":"153","author":"Racine","year":"","journal-title":"Pain"},{"key":"B35","first-page":"827","article-title":"Cell proliferation in carcinoid valve disease: a mechanism for serotonin effects","volume":"10","author":"Rajamannan","year":"2001","journal-title":"J. heart valve Dis."},{"key":"B36","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.yebeh.2018.08.032","article-title":"Burden of illness in patients with possible Lennox-Gastaut syndrome: a retrospective claims-based study","volume":"88","author":"Reaven","year":"2018","journal-title":"Epilepsy and Behav."},{"key":"B37","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1093\/icvts\/ivx153","article-title":"Increased blood levels of transforming growth factor \u03b2 in patients with aortic dilatation","volume":"25","author":"Rueda-Mart\u00ednez","year":"2017","journal-title":"Interact. Cardiovasc. Thorac. Surg."},{"key":"B38","doi-asserted-by":"publisher","first-page":"e41486","DOI":"10.1016\/j.heliyon.2024.e41486","article-title":"Development of cohort definitions and algorithms to identify patients with Lennox-Gastaut syndrome or Dravet syndrome from real-world administrative healthcare databases","volume":"11","author":"Shah","year":"2025","journal-title":"Heliyon"},{"key":"B39","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.pscychresns.2005.02.008","article-title":"Gender differences in a fenfluramine-activated FDG PET study of borderline personality disorder","volume":"138","author":"Soloff","year":"2005","journal-title":"Psychiatry Res. Neuroimaging"},{"key":"B40","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1111\/epi.17866","article-title":"A systematic literature review on the global epidemiology of Dravet syndrome and Lennox-Gastaut syndrome: prevalence, incidence, diagnosis, and mortality","volume":"65","author":"Sullivan","year":"2024","journal-title":"Epilepsia"},{"key":"B41","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1007\/s40120-023-00452-1","article-title":"Efficacy and safety of fenfluramine in epilepsy: a systematic review and meta-analysis","volume":"12","author":"Tabaee Damavandi","year":"2023","journal-title":"Neurology Ther."},{"key":"B42","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1111\/epi.16456","article-title":"New insights into the early mechanisms of epileptogenesis in a zebrafish model of Dravet syndrome","volume":"61","author":"Tiraboschi","year":"2020","journal-title":"Epilepsia"},{"key":"B43","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1002\/pds.668","article-title":"A comparison of measures of disproportionality for signal detection in spontaneous reporting systems for adverse drug reactions","volume":"11","author":"van Puijenbroek","year":"2002","journal-title":"Pharmacoepidemiol. drug Saf."},{"key":"B44","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1111\/epi.17274","article-title":"International consensus on diagnosis and management of Dravet syndrome","volume":"63","author":"Wirrell","year":"2022","journal-title":"Epilepsia"},{"key":"B45","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1002\/epi4.12998","article-title":"Practical considerations for the use of fenfluramine to manage patients with Dravet syndrome or Lennox-Gastaut syndrome in clinical practice","volume":"9","author":"Wirrell","year":"2024","journal-title":"Epilepsia open"}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2025.1682788\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T05:42:34Z","timestamp":1758692554000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2025.1682788\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,24]]},"references-count":45,"alternative-id":["10.3389\/fphar.2025.1682788"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2025.1682788","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,24]]},"article-number":"1682788"}}